OverviewSuggest Edit

CLINUVEL PHARMACEUTICALS is a company that provides drugs for the treatment of severe skin disorders. It develops SCENESSE, a compound targeting erythropoietic protoporphyria (EPP). In addition, the company specializes in photomedicine and photocare areas.
HQMelbourne, AU


CLINUVEL is headquartered in
Melbourne, Australia

Location Map

Latest Updates

Share Price (Jul 2020)$24.4 (-2%)
Cybersecurity ratingCMore

CLINUVEL Office Locations

CLINUVEL has offices in Melbourne, Burlingame, Dublin, Singapore and in 2 other locations
Melbourne, AU (HQ)
level 11/535 Bourke St
Dublin, IE
10 Earlsfort Terrace, Saint Kevin's
Singapore, SG
51 Science Park Rd
Baar, CH
Zugerstrasse 76A
Leatherhead, GB
Wesley house, Bull Hill
Burlingame, US
One Bay Plaza, 1350 Old Bayshore Hwy #520
Show all (6)

CLINUVEL Financials and Metrics


Market capitalization (9-Jul-2020)


Closing stock price (9-Jul-2020)

CLINUVEL's current market capitalization is $1.2 b.
Show all financial metrics

CLINUVEL Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

CLINUVEL Online and Social Media Presence

Embed Graph

CLINUVEL Frequently Asked Questions

  • When was CLINUVEL founded?

    CLINUVEL was founded in 2001.

  • Who are CLINUVEL competitors?

    Competitors of CLINUVEL include Athersys, Reata Pharmaceuticals and Otonomy.

  • Where is CLINUVEL headquarters?

    CLINUVEL headquarters is located at level 11/535 Bourke St, Melbourne.

  • Where are CLINUVEL offices?

    CLINUVEL has offices in Melbourne, Burlingame, Dublin, Singapore and in 2 other locations.

  • How many offices does CLINUVEL have?

    CLINUVEL has 6 offices.